According to Sawyer Merritt on Twitter, Neuralink is prepared to implant its new brain chip, Blindsight, into a human patient for the first time, pending regulatory approval. This device is designed to restore vision in individuals with complete loss of sight. As reported by Sawyer Merritt, Elon Musk stated that the Blindsight chip could enable those who are totally blind to regain visual perception. This marks a significant advance in neurotechnology applications for medical AI and could open new business opportunities in neural prosthetics and assistive tech, according to Sawyer Merritt.

According to @ai_darpa, Neuralink is advancing its AI-powered brain-computer interface technology with its latest project, Blindsight, aiming to restore vision even for individuals born blind or lacking eyes or optic nerves. The company has already achieved low-resolution vision restoration in monkeys, with human clinical trials awaiting FDA approval. This development highlights a major leap in AI-enabled medical devices and brain tech, opening significant business opportunities in the assistive technology market and demonstrating the practical impact of Neuralink's AI innovations on neural prosthetics for sensory restoration (source: @ai_darpa, Dec 20, 2025).